Product image of Levosimendan Kabi (Levosimendan) supplied by GNH India

Levosimendan Kabi

Active Ingredient:
Levosimendan
Origin:
EU

Levosimendan Kabi (Levosimendan)

Levosimendan, the active ingredient in Levosimendan Kabi, is a calcium sensitizer presented as a sterile intravenous solution for infusion use. It increases cardiac contractility and promotes vasodilation, making it suitable for the treatment of acute decompensated heart failure in adult patients.

GNH India supplies Levosimendan Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Fresenius Kabi Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levosimendan is used in the management of acute heart failure, acting as an inotropic and vasodilating agent.

  • Acute decompensated heart failure: improves cardiac output and reduces symptoms of low perfusion.
  • Acute decompensated heart failure: decreases pulmonary capillary wedge pressure, helping relieve congestion.
  • Acute decompensated heart failure: facilitates weaning from mechanical ventilation or circulatory support in stabilized patients.

How It Works

  • Levosimendan binds to cardiac troponin C, increasing its sensitivity to calcium and thereby enhancing contractile force without raising intracellular calcium levels. It also opens ATP‑sensitive potassium channels in vascular smooth muscle, producing vasodilation and reducing afterload, which together improve cardiac output in heart failure patients.

Side Effects

Levosimendan may be associated with several adverse reactions, which are classified by frequency.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal upset.
  • Hypotension: transient drop in blood pressure.
  • Arrhythmias: occasional ventricular ectopy.
  • Flushing: warm sensation with skin reddening.
  • Dizziness: related to blood pressure changes.

Serious or Rare Side Effects

  • Severe hypotension: may require vasopressor support.
  • Life‑threatening arrhythmias: ventricular tachycardia or fibrillation.
  • Allergic reactions: anaphylaxis or severe skin rash.

Precautions & Warnings

Levosimendan requires careful monitoring and specific safety measures before and during therapy.

  • Cardiovascular monitoring: continuous ECG and blood pressure monitoring is required during infusion.
  • Electrolyte balance: correct potassium and magnesium levels before administration.
  • Renal function: assess renal function as dosage may need adjustment in severe impairment.
  • Hepatic impairment: use with caution in patients with significant liver disease.
  • Concomitant vasodilators: monitor for excessive hypotension when combined with other vasodilators.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Levosimendan can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations of levosimendan.
  • Concurrent use with other inotropes (e.g., dobutamine): can cause excessive cardiac stimulation.
  • Nitrates or phosphodiesterase‑5 inhibitors: risk of profound hypotension.

Moderate Interactions (Monitor Closely)

  • Diuretics: may potentiate hypotensive effects; monitor blood pressure.
  • Beta‑blockers: may blunt the inotropic response; adjust dosing as needed.
  • Anticoagulants: monitor coagulation parameters as levosimendan can affect platelet function.

Frequently Asked Questions

Levosimendan Kabi is indicated for the treatment of acute decompensated heart failure in adult patients. It works as an inotropic and vasodilating agent to improve cardiac output and relieve symptoms associated with low cardiac performance.

Levosimendan increases the sensitivity of cardiac troponin C to calcium, enhancing contractile force without raising intracellular calcium. It also opens ATP‑sensitive potassium channels in vascular smooth muscle, causing vasodilation and reducing afterload, which together support heart function.

The dosing regimen for Levosimendan Kabi is determined by the prescribing clinician based on the patient’s clinical status, weight, and response. It is administered as an intravenous infusion, and the exact rate and duration are individualized.

Safety data for levosimendan in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Levosimendan Kabi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike traditional catecholamine inotropes like dobutamine, levosimendan enhances contractility without increasing intracellular calcium and also provides vasodilation through potassium‑channel activation. This dual action can result in improved cardiac output with a lower risk of tachyarrhythmias, though individual patient response varies.

Levosimendan Kabi should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze the solution, and keep it in the original packaging to maintain sterility until it is prepared for infusion.

Levosimendan Kabi is given by intravenous infusion, typically after a loading dose followed by a maintenance infusion. Administration is performed under continuous cardiovascular monitoring in a hospital setting to observe blood pressure, heart rhythm and hemodynamic response.

The most serious risks include severe hypotension, life‑threatening arrhythmias such as ventricular tachycardia, and rare allergic reactions like anaphylaxis. Prompt recognition and management of these events are essential during infusion.

Levosimendan Kabi is contraindicated in patients with severe hypotension, uncontrolled ventricular arrhythmias, or known hypersensitivity to the drug. Caution is also advised in individuals with significant hepatic impairment or those receiving other potent vasodilators.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levosimendan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT